Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study Highlights Drug Targets for Allergies, Asthma

February 18, 2015 2:56 pm | by Sam Wong, Imperial College London | News | Comments

The new findings could lead to new treatments for allergic diseases, and will help to predict who will best respond to currently available treatments. Read more...                

TOPICS:

The Ebola Era

February 18, 2015 2:45 pm | by Harvard Medical School | News | Comments

This event will convene international experts in virology, infectious disease, vaccines and therapeutics. They will discuss strategies both to combat the current Ebola outbreak. Read more...            

TOPICS:

More Measles Cases Tied to Disneyland, Illinois Day Care

February 18, 2015 2:39 pm | by Mike Stobbe, AP Medical Writer | News | Comments

The number of U.S. measles cases this year has risen to 141, with most of the new illnesses tied to outbreaks at Disneyland in California and an Illinois day care center. Read more...             

TOPICS:
Advertisement

Scientists Announce Anti-HIV Agent So Powerful It Can Work in a Vaccine

February 18, 2015 2:34 pm | by Scripps Research Institute | News | Comments

Scientists have announced the creation of a novel drug candidate that is so potent and universally effective, it might work as part of an unconventional vaccine. Read more...              

TOPICS:

Is Strenuous Running Really as Bad for Health as Lounging?

February 18, 2015 11:10 am | by Cynthia Fox, Science Editor | News | Comments

Running hard may be as bad for your longevity as being a couch potato, says a recent study—one that should be taken with a grain of salt (hold the butter), say some critics. The study, in a recent Journal of the American College of Cardiology, examined 5,048 healthy people enrolled in the Copenhagen City Heart Study. For 12 years, 1,098 healthy joggers and 413 healthy, but sedentary non-joggers were followed.

TOPICS:

FDA Expands Indications for Revlimid

February 18, 2015 10:40 am | by Associated Press | News | Comments

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has expanded the existing indication for Revlimid (lenalidomide) in combination with dexamethasone to include patients newly diagnosed with multiple myeloma (NDMM). Read more..

TOPICS:

Tadpole Model Links Drug Exposure to Autism-Like Effects

February 18, 2015 10:31 am | by Brown University | News | Comments

Research suggests that fetal exposure to chemicals or drugs can cause neurological problems. Babies whose mothers take the epilepsy drug valporic acid (VPA) during pregnancy, for example, appear to have an elevated risk of developing an autism spectrum disorder. Read more...

TOPICS:

After Lobbying Push, Drugmaker Resubmits Women's Sex Pill

February 18, 2015 10:21 am | by Matthew Perrone, AP Health Writer - Associated Press | News | Comments

The makers of a twice-rejected pill designed to boost sexual desire in women are hoping a yearlong lobbying push by politicians, women's groups and consumer advocates will move their much-debated drug onto the market. The ongoing saga of Sprout Pharmaceutical's female libido drug illustrates the complicated politics and unresolved science surrounding women's sexuality. Read more...

Advertisement

Taking Technology from the Lab to the Patient

February 18, 2015 10:17 am | by MIT | News | Comments

After finishing his PhD in molecular genetics in the late 1990s, Daniel Anderson found himself conflicted about what to do next: He enjoyed science, but wanted to find a way to have a direct impact on human health. Read more...

TOPICS:

Senior Pharmaceutical Executives Establish Business, next20

February 18, 2015 10:03 am | News | Comments

Three highly-experienced pharmaceutical and healthcare industry executives have formed next20, a new "Thought Partnership" which provides strategic support to help healthcare and pharmaceutical companies of all sizes identify and fully-leverage revenue opportunities. Read more...

TOPICS:

Oncolytics: Enrollment Completion for Phase 2 Randomized Colorectal Cancer Study

February 18, 2015 9:08 am | News | Comments

The trial is being sponsored and conducted by the NCIC Clinical Trials Group. Read more...                            

TOPICS:

New Drug Target for Multiple Sclerosis Discovered

February 18, 2015 8:59 am | by Centre for Addiction and Mental Health | News | Comments

Scientists have discovered a promising new approach to treat multiple sclerosis. Read more...                            

TOPICS:

Lung Cancer Breath Test in Clinical Trial

February 18, 2015 8:55 am | by University of Leicester | News | Comments

A clinical trial exploring a potentially ground-breaking ‘breath test’ to detect lung cancer is set to get underway. Read more...                      

TOPICS:

Computer Algorithm Picks Out the Drugs that Work

February 18, 2015 8:49 am | by Oxford University | News | Comments

More than 90 percent of central nervous system drugs fail when they're tried in large human trials. Read more...                         

TOPICS:

Actavis Plans Corporate Name Change to Allergan

February 18, 2015 8:44 am | News | Comments

Actavis will change the company name after the completed acquisition of Allergan. Read more...                            

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading